Capnography Devices Domain to Grow Owing to Increasing Respiratory Disease Prevalence
Capnography devices
have become indispensable in the healthcare sector, owing to the rise in
geriatric population and number of respiratory disease incidents. The global
capnography devices market was valued at $384.2 million in 2017 and is expected
to attain a CAGR of 18.2% during the forecast period (2018–2025) because of
rising government initiatives and technological advancements.
Monitoring devices used for the measurement of the carbon
dioxide (CO2) concentration in exhaled air are known as capnography devices.
This is why these are used extensively during intensive care and anesthesia
procedures. The capnography devices market is segmented by product, component,
technology, end-user, and application. The product segment comprises the
stand-alone, hand-held, and multi-parameter categories. Hand-held capnographs
were the largest category in 2017, with a revenue contribution of 62.2%. Owing
to their greater flexibility, hand-held capnographs can be used in various
patient care settings, an advantage that is leading to their growing
popularity.
Request to Get the Sample Pages at:
On a global ground, North America emerged as the largest
capnography devices market, accounting for 56.4% revenue contribution in 2017.
The rising prevalence of respiratory conditions and growing aging population
along with well-established healthcare facilities and the presence of leading
market players manufacturing these devices have been instrumental in driving
the North American market forward. The market is being driven by a number of
factors.
With the integration of molecular spectroscopy and photo
detectors in micro stream capnographs and the adoption of miniaturized
mainstream multi-gas monitors, capnography devices have become more accurate
and safer and can now collect a larger volume sample as compared to
conventional equipment. Technological innovations have also helped in making
capnography devices portable and automatic, thus widening their reach beyond
hospital setups and into home settings to monitor severely compromised
pulmonary patients.
Therefore, the market is slated to grow during the forecast
period owing to the popularity of home monitoring of patients.
Comments
Post a Comment